ProtOS Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

ProtOS General Information

Description

Developer of an AI-first protein research and development platform designed to create biotherapeutics to treat undruggable diseases. The company's platform uses proprietary AI models and structural biology to design de novo AI-proteins and create novel biotherapeutics that are highly specific and effective in degrading previously undruggable pathways by interacting with proteins of interest beyond the reach of small molecules and antibodies, enabling clients to get significant advantages over existing PROTAC and molecular glue approaches.

Contact Information

Website
www.protos.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 20 King George Street, 3rd Floor
  • Jerusalem 9426202
  • Israel
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 20 King George Street, 3rd Floor
  • Jerusalem 9426202
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProtOS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Sep-2025 Completed Generating Revenue
To view ProtOS’s complete valuation and funding history, request access »

ProtOS Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProtOS Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fresh.Fund Venture Capital Minority
Good Company (Israel) Venture Capital Minority
To view ProtOS’s complete investors history, request access »

ProtOS FAQs

  • When was ProtOS founded?

    ProtOS was founded in 2023.

  • Where is ProtOS headquartered?

    ProtOS is headquartered in Jerusalem, Israel.

  • What is the size of ProtOS?

    ProtOS has 3 total employees.

  • What industry is ProtOS in?

    ProtOS’s primary industry is Drug Discovery.

  • Is ProtOS a private or public company?

    ProtOS is a Private company.

  • What is ProtOS’s current revenue?

    The current revenue for ProtOS is .

  • Who are ProtOS’s investors?

    Fresh.Fund and Good Company (Israel) have invested in ProtOS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process